Section scientifique
561 articles publiés dans publications évaluées par experts jusqu'à présent
- Dendritic cells: the yin and yang in disease progression
-
Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis Achieved Ulcer Healing for Pyoderma Gangrenosum
-
MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis
anti-TNFα / combiantion / gma / GMAs responders / IBD / intensive / miRNAs / transcriptomics / ulcerative colitis /Lire la suite
-
A case of refractory immune checkpoint inhibitor-induced colitis improved by the treatment with vedolizumab and granulocyte-monocyte apheresis combination therapy
-
A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis
- A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis
-
Therapeutic Granulomonocytapheresis as a Non-pharmacologic Treatment Option for Inflammatory Bowel Disease: Efficacy Reports on a Wide Age Range and Disease Profile
apoptosis / efficacy / efficay / gma / GMAs responders / IBD / IL-10 / loss of mucosal tissue / neutrophil / pediatric / regulatory B cells / Safety /Lire la suite
-
Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review
case report / comorbidities / EIM / elderly / Frail / gma / intensive / Pyoderma gangrenosum / Refractory patients / Safety / severe / ulcerative colitis / vedolizumab /Lire la suite
-
Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review
-
Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review
case report / combination / efficacy / EIM / Frail / gma / intensive / Pyoderma gangrenosum / Safety / ulcerative colitis / vedolizumab /Lire la suite
-
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update
-
Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis (UC): evidence from a systematic literature review (SLR)
ASUC / Clinical remission / cohort / cyclosporine / efficacy / gma / golimumab / Infliximab / moderate to severe / Multicenter / observational / Safety / steoids / study / systematic literature review / Tacrolimus / tofacitinib / ulcerative colitis / Ustekinumab / vedolizumab /Lire la suite
Contactez-nousPour en savoir plus
Contactez-nous